Linear Intervention and Non-traditional Targets for Atrial Fibrillation

Article

This pair of webcasts features presentations on the role of linear ablation in treating atrial fibrillation and targets for non-ionic channel therapies.

This pair of webcasts features presentations on the role of linear ablation in treating atrial fibrillation and targets for non-ionic channel therapies.

Ablation of Persistent and Chronic AF: Extensive Linear Intervention for Cure and Palliation

This presentation from the Heart Rhythm Society features Pierre Jais, MD, Hopital Haut Leveque, Bordeaux-Pessac, France, and Mark S. Kremers, MD, MidCarolina Cardiology, Charlotte, NC, who review quantitative data on the role of linear ablation in treating atrial fibrillation and provide “additional insights into other etiologies of atrial tachycardias that may occur after linear ablation.”

Non-traditional Targets for Atrial Fibrillation In this webcast, Katherine A. Murray, MD, Vanderbilt Medical Center, Nashville, TN, discusses targets for non-ionic channel therapies for treating atrial fibrillation (AF), non-traditional agents as potential treatments for AF, the role of the rennin-angiotensin system in AF, and non-traditional agents in post-operative AF.

Related Videos
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
Video 4 - "Innovations in Small Interfering RNA (siRNA) Therapy"
Video 3 - "Ongoing Lp(a) Trials and Clinical Approaches to Treatment"
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Payal Kohli, MD | Credit: Cherry Creek Heart
Matthew Nudy, MD | Credit: Penn State Health
Kelley Branch, MD, MSc | Credit: University of Washington Medicine
Kelley Branch, MD, MS | Credit: University of Washington Medicine
David Berg, MD, MPH | Credit: Brigham and Women's
© 2024 MJH Life Sciences

All rights reserved.